An analytical framework for immunization programs in Canada
- 31 March 2005
- Vol. 23 (19) , 2470-2476
- https://doi.org/10.1016/j.vaccine.2004.10.029
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Cost-effectiveness of immunization strategies for the control of serogroup C meningococcal diseaseVaccine, 2004
- Varicella vaccination: Impact of vaccine efficacy on the epidemiology of VZVJournal of Medical Virology, 2003
- A Pharmacoeconomic Evaluation of 7‐Valent Pneumococcal Conjugate Vaccine in CanadaClinical Infectious Diseases, 2003
- The Effect of Vaccination on the Epidemiology of Varicella Zoster VirusJournal of Infection, 2002
- The Changing Age and Seasonal Profile of Pertussis in CanadaThe Journal of Infectious Diseases, 2002
- Pertussis Is a Frequent Cause of Prolonged Cough Illness in Adults and AdolescentsClinical Infectious Diseases, 2001
- Invasive Pneumococcal Infections in Canadian Children, 1991-1998: Implications for New Vaccination StrategiesClinical Infectious Diseases, 2000
- A benefit-cost analysis of two-dose measles immunization in CanadaVaccine, 1998
- Influence of disease burden, public perception, and other factors on new vaccine development, implementation, and continued useThe Lancet, 1997
- Five‐Hundred Life‐Saving Interventions and Their Cost‐EffectivenessRisk Analysis, 1995